DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video SINGAPORE, Nov. 13, 2026 /PRNewswire/ -- DomoAI, the AI video platform used by more than 5 million creators, today announced InkoAI ...
TONEY, AL / ACCESS Newswire / November 12, 2026 / Dayton T. Brown, Inc. (DTB), a U.S.-owned provider of independent testing ...
Student-athletes will visit elementary schools in the Greater Pittsburgh area to inspire students through reading, mentorship ...
DUBAI, UAE / ACCESS Newswire / November 12, 2026 / Alex Bodi appears to have succeeded in winning over the majority shareholder of the SCANDIC Group, which operates worldwide. A proprietary card brand ...
NORTHAMPTON, MA / ACCESS Newswire / November 12, 2026 / GP PRO, a division of Georgia-Pacific, is an industry leader in advanced dispensing and smart monitoring solutions in commercial spaces.The busi ...
As business owners ask why their moving company or staffing agency does not appear in AI-generated answers, AI Search Engineers outlines six practical steps for improving how AI tools describe a busin ...
With more than 20 years of experience, Hartland will lead business valuation services supporting ownership transitions, tax ...
Company leverages existing water infrastructure and manufacturing capabilities to pursue diversified commercial growth MARION ...
As lead investor and technical partner, Airsys supplies the LiquidPack spray cooling inside ThermAI's HeatBridge prototype, ...
VANCOUVER, BC / ACCESS Newswire / November 12, 2026 / Meta Critical Minerals Inc. (the " Company " or " Meta ") (CSE:MTTA)(OTCQB:MTTAF)(FSE:VJ3) is pleased to announce that it has completed a high-res ...
Avatar Capital Partners Secures US$156 Million First Close for Fund II and Forms Strategic Partnership with GCM Grosvenor and Teacher Retirement System of Texas Fund II is targeting US$300 million ...
SEATTLE, WA / ACCESS Newswire / November 12, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-onc ...